JP2012532889A - 創傷治療方法及び傷跡変性方法 - Google Patents

創傷治療方法及び傷跡変性方法 Download PDF

Info

Publication number
JP2012532889A
JP2012532889A JP2012519777A JP2012519777A JP2012532889A JP 2012532889 A JP2012532889 A JP 2012532889A JP 2012519777 A JP2012519777 A JP 2012519777A JP 2012519777 A JP2012519777 A JP 2012519777A JP 2012532889 A JP2012532889 A JP 2012532889A
Authority
JP
Japan
Prior art keywords
wound
scar
pharmaceutical composition
corticosteroid
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012519777A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012532889A5 (cg-RX-API-DMAC7.html
Inventor
ケラー、ブライアン、シー．
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Crescendo Therapeutics LLC
Original Assignee
Crescendo Therapeutics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crescendo Therapeutics LLC filed Critical Crescendo Therapeutics LLC
Publication of JP2012532889A publication Critical patent/JP2012532889A/ja
Publication of JP2012532889A5 publication Critical patent/JP2012532889A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2012519777A 2009-07-09 2010-07-09 創傷治療方法及び傷跡変性方法 Pending JP2012532889A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22440809P 2009-07-09 2009-07-09
US61/224,408 2009-07-09
US22621609P 2009-07-16 2009-07-16
US61/226,216 2009-07-16
PCT/US2010/041576 WO2011006100A1 (en) 2009-07-09 2010-07-09 Method of wound healing and scar modulation

Publications (2)

Publication Number Publication Date
JP2012532889A true JP2012532889A (ja) 2012-12-20
JP2012532889A5 JP2012532889A5 (cg-RX-API-DMAC7.html) 2013-09-05

Family

ID=43427950

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012519777A Pending JP2012532889A (ja) 2009-07-09 2010-07-09 創傷治療方法及び傷跡変性方法

Country Status (10)

Country Link
US (1) US20110009374A1 (cg-RX-API-DMAC7.html)
EP (1) EP2451280A4 (cg-RX-API-DMAC7.html)
JP (1) JP2012532889A (cg-RX-API-DMAC7.html)
CN (1) CN102480969A (cg-RX-API-DMAC7.html)
AR (1) AR077410A1 (cg-RX-API-DMAC7.html)
AU (1) AU2010271205A1 (cg-RX-API-DMAC7.html)
BR (1) BR112012001098A2 (cg-RX-API-DMAC7.html)
CA (1) CA2767661A1 (cg-RX-API-DMAC7.html)
MX (1) MX2012000434A (cg-RX-API-DMAC7.html)
WO (1) WO2011006100A1 (cg-RX-API-DMAC7.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100322875A1 (en) 2009-06-18 2010-12-23 Advanced Bio-Technologies, Inc. Silicone scar treatment preparation
US8623040B2 (en) 2009-07-01 2014-01-07 Alcon Research, Ltd. Phacoemulsification hook tip
WO2012012390A1 (en) 2010-07-19 2012-01-26 Marvphyt Development Llc Botanical composition and methods of manufacture and use
US10258505B2 (en) 2010-09-17 2019-04-16 Alcon Research, Ltd. Balanced phacoemulsification tip
ITMI20111050A1 (it) * 2011-06-10 2012-12-11 Sevecom Spa Uso di emulsionanti in associazione con oleine vegetali in un alimento per animali.
CN103648483A (zh) 2011-06-24 2014-03-19 莫茨制药有限及两合公司 包含洋葱提取物和脂质体的组合物
US9364510B2 (en) 2011-07-19 2016-06-14 Marvphyt Development Llc Botanical composition and methods of manufacture and use
LT2736887T (lt) 2011-07-29 2018-02-12 Karyopharm Therapeutics, Inc. Hidrazidą turintys branduolių transporto moduliatoriai ir jų panaudojimas
WO2013040265A1 (en) * 2011-09-13 2013-03-21 Brigham Young University Technology Commercialization Office Compositions for treating bone diseases and broken bones
US9474685B2 (en) 2011-09-28 2016-10-25 Sure-Shot Medical Device Inc. Apparatus for localized dermatological treatment
GB201120724D0 (en) * 2011-12-01 2012-01-11 Gauthier Rene System and method for alleviating the appearance of scars and/or scar tissue
FR2985064B1 (fr) * 2011-12-23 2016-02-26 Oreal Procede pour delivrer un conseil cosmetique
JP6093007B2 (ja) * 2012-04-27 2017-03-08 ダウ コーニング コーポレーションＤｏｗ Ｃｏｒｎｉｎｇ Ｃｏｒｐｏｒａｔｉｏｎ 基質に有効成分を送達するためのシリコーン系賦形剤を含有する局所用製剤組成物
HUE040427T2 (hu) 2012-05-09 2019-03-28 Biogen Ma Inc Nukleáris transzportmodulátorok és felhasználásuk
US11458199B2 (en) * 2012-08-21 2022-10-04 Opko Pharmaceuticals, Llc Liposome formulations
US9808654B2 (en) * 2013-02-11 2017-11-07 Jan Marini Skin Research Post procedure skin care gel and methods of use thereof
EP2968278B8 (en) * 2013-03-15 2019-05-22 Karyopharm Therapeutics Inc. Methods of promoting wound healing using crm1 inhibitors
CN105122261B (zh) * 2013-04-23 2020-04-24 惠普发展公司，有限责任合伙企业 从遭到破坏的系统启动代码中恢复的方法以及计算装置
EP3492455B1 (en) 2013-06-21 2023-05-17 Karyopharm Therapeutics Inc. 1,2,4-triazoles as nuclear transport modulators and use in the treatment of specific forms of cancer
US11432990B2 (en) 2013-08-30 2022-09-06 ISOS Solutions, LLC Textured apparatus with therapeutic material incorporated therein and methods of manufacturing same
US9226890B1 (en) 2013-12-10 2016-01-05 Englewood Lab, Llc Polysilicone base for scar treatment
EP3087495A4 (en) * 2013-12-23 2017-08-23 Intel Corporation Integrated component interconnect
JP7017311B2 (ja) 2014-06-09 2022-02-08 広東科洛克生物医薬集団有限公司 シリコンベースの生体光組成物およびその使用
MA40433A (fr) 2014-07-21 2017-06-14 Sevecom Spa Émulsion en poudre pour aliments pour animaux
EA201790384A1 (ru) 2014-08-15 2017-08-31 Кариофарм Терапевтикс, Инк. Полиморфы селинексора
MA43529A (fr) 2015-12-31 2018-11-07 Karyopharm Therapeutics Inc Modulateurs de transport nucléaire et leurs utilisations
WO2017117535A1 (en) 2015-12-31 2017-07-06 Karyopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
WO2018098472A1 (en) 2016-11-28 2018-05-31 Karyopharm Therapeutics Inc. Crm1 inhibitors for treating epilepsy
JP7595413B2 (ja) 2016-11-30 2024-12-06 ケース ウエスタン リザーブ ユニバーシティ １５－ｐｇｄｈ阻害剤とコルチコステロイドおよび／またはｔｎｆ阻害剤との組み合わせならびにその使用
EP3576737A4 (en) 2017-02-06 2021-04-21 Case Western Reserve University COMPOSITIONS AND METHODS OF MODULATING THE ACTIVITY OF SHORT CHAIN DEHYDROGENASE
CA3114363A1 (en) * 2018-09-28 2020-04-02 Joel Studin Transpore delivery of steroids and large molecules
EP3883577A4 (en) 2018-11-21 2022-06-15 Case Western Reserve University COMPOSITIONS AND METHODS FOR MODULATION OF SHORT CHAIN DEHYDROGENASE ACTIVITY
US20200397720A1 (en) * 2019-06-23 2020-12-24 Charles Huntington Gallina Method and formulation for treatment of wounds by new tissue regeneration with reduced trauma and scar tissue formation
CN110368498A (zh) * 2019-08-26 2019-10-25 瑞希(重庆)生物科技有限公司 一种促进伤口愈合的制剂及其制备方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010068955A (ko) * 2000-01-11 2001-07-23 조용준 외피용약제 조성물
JP2003081812A (ja) * 2001-07-05 2003-03-19 Rohto Pharmaceut Co Ltd エアゾール製剤
JP2003514835A (ja) * 1999-11-17 2003-04-22 ディ・エスジー・ライセンシング・コーポレイション 瘢痕を治療する方法と組成物
JP2003321347A (ja) * 2002-05-07 2003-11-11 Rohto Pharmaceut Co Ltd ゲル軟膏
JP2006521356A (ja) * 2003-03-28 2006-09-21 ファルマシア・コーポレーション シクロオキシゲナーゼ−２阻害薬を使用することによるステロイド節約効果をもたらす方法、およびシクロオキシゲナーゼ−２阻害薬を含む組成物
JP2008502647A (ja) * 2004-06-17 2008-01-31 ガルデルマ・ソシエテ・アノニム シリコーン剤、コルチコステロイドおよびビタミンｄまたはその誘導体を含む乾癬治療用組成物
WO2008109887A1 (en) * 2007-03-08 2008-09-12 Biozone Laboratories Inc. Dressing formulations to prevent and reduce scarring

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1443062A (zh) * 2000-05-23 2003-09-17 荷兰联合利华有限公司 除臭剂和/或防汗剂组合物
GB0018466D0 (en) * 2000-07-27 2000-09-13 Strakan Pharm Ltd Keloid Treatment
US6610322B1 (en) * 2000-12-20 2003-08-26 Brian Charles Keller Self forming, thermodynamically stable liposomes and their applications
US6495596B1 (en) * 2001-03-23 2002-12-17 Biozibe Laboratories, Inc. Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase-2
US6998421B2 (en) * 2001-06-07 2006-02-14 Biozone Laboratories, Inc. Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase - 2
GB0216427D0 (en) * 2002-07-16 2002-08-21 Advanced Biotechnologies Inter Wound dressing
WO2005009342A2 (en) * 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
KR20080016612A (ko) * 2005-06-10 2008-02-21 갈데르마 소시에떼아노님 약물, 필름형성 실리콘 및 하나 이상의 휘발성 용매를포함하는 국소조성물을 기초로 하는 피부를 통한 약물의조절된 방출
US20080317830A1 (en) * 2007-06-25 2008-12-25 Liolabs Llc Compositions and Methods for the Treatment of Wounds and Scar Tissue
DE102009030931A1 (de) * 2009-06-24 2010-12-30 Eberhard-Karls-Universität Tübingen Universitätsklinikum Chirurgisches Wundverschlusselement

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003514835A (ja) * 1999-11-17 2003-04-22 ディ・エスジー・ライセンシング・コーポレイション 瘢痕を治療する方法と組成物
KR20010068955A (ko) * 2000-01-11 2001-07-23 조용준 외피용약제 조성물
JP2003081812A (ja) * 2001-07-05 2003-03-19 Rohto Pharmaceut Co Ltd エアゾール製剤
JP2003321347A (ja) * 2002-05-07 2003-11-11 Rohto Pharmaceut Co Ltd ゲル軟膏
JP2006521356A (ja) * 2003-03-28 2006-09-21 ファルマシア・コーポレーション シクロオキシゲナーゼ−２阻害薬を使用することによるステロイド節約効果をもたらす方法、およびシクロオキシゲナーゼ−２阻害薬を含む組成物
JP2008502647A (ja) * 2004-06-17 2008-01-31 ガルデルマ・ソシエテ・アノニム シリコーン剤、コルチコステロイドおよびビタミンｄまたはその誘導体を含む乾癬治療用組成物
WO2008109887A1 (en) * 2007-03-08 2008-09-12 Biozone Laboratories Inc. Dressing formulations to prevent and reduce scarring

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VOENNO-MEDITSINSKII ZHURNAL, vol. 2, JPN7014002301, 1982, pages 26 - 30, ISSN: 0002865321 *

Also Published As

Publication number Publication date
EP2451280A1 (en) 2012-05-16
BR112012001098A2 (pt) 2015-09-01
AU2010271205A1 (en) 2012-02-09
CN102480969A (zh) 2012-05-30
CA2767661A1 (en) 2011-01-13
EP2451280A4 (en) 2012-12-26
WO2011006100A1 (en) 2011-01-13
AR077410A1 (es) 2011-08-24
MX2012000434A (es) 2012-04-11
US20110009374A1 (en) 2011-01-13

Similar Documents

Publication Publication Date Title
JP2012532889A (ja) 創傷治療方法及び傷跡変性方法
US8945636B2 (en) Stabilized formulation comprising omega-3 fatty acids and use of the fatty acids for skin care and/or wound care
CA2891602C (en) Composition comprising an orthosilicate and its use for tissue regeneration
JP5897164B2 (ja) 外用組成物
US20100105644A1 (en) Botanical composition for enhanced skin repair and uses thereof
TW201210601A (en) Compounds and methods for skin repair
US20110189307A1 (en) Methods and compositions for oxygenation of skin to treat skin disorders
AU2012368815B2 (en) A composition and use thereof in the treatment of anal rhagades
US20220105062A1 (en) Transdermal penetrant formulations
US9555053B2 (en) Use of oligosaccharide compounds for the prevention and treatment of pathological scars
US20080220068A1 (en) Treatment and prevention of excessive scarring
EP2046310B1 (en) Treatment and prevention of excessive scarring
CN117651553A (zh) 用于治疗萎缩性瘢痕的犬尿氨酸及其衍生物
US20140350117A1 (en) Topical Scar Treatment Composition and Method of Using Same
WO2020175131A1 (ja) 脈管異常治療用外用剤
TWI899828B (zh) 乳液、醫藥組成物及外用組成物
TWI862350B (zh) 治療表皮分解性水疱症的方法
EP3079691B1 (en) Pharmaceutical composition comprising dantrolene as ryanodine receptor antagonist for facilitating wound healing
WO2011123619A2 (en) Permeable mixtures, methods and compositions for the skin
KR102113317B1 (ko) 흉터의 예방 또는 치료를 위한 조성물
CN110996977A (zh) 用于缓解或治疗灼伤及褥疮的组合物
CN121129869A (zh) 一种用于皮肤修复的组合物及其制备方法和应用
TW202529729A (zh) 乳液、醫藥組成物及外用組成物
RU2578969C1 (ru) Средство для лечения повреждений наружных тканей организма (варианты) и способ его получения
EP1891945A1 (en) Treatment and prevention of excessive scarring

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130705

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130705

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140729

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141029

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141106

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141118

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141126

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141225

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150407